Tissue-specific Vector Design
Tissue-Specific Vector Design is a gene delivery vector development strategy that belongs to the class of targeted therapeutic design methodologies, distinguished by its explicit engineering of vector components to selectively transduce specific tissue types through the incorporation of tissue-restricted promoters, ligands, or envelope proteins.
9
Publications
422
Citations
85
Authors
34
Institutions
Publications per year
2017–2026
2
Parents
9
Designing gene therapy vectors: avoiding immune responses by using tissue-specific promoters
RD Weeratna, Tong Wu, SM Efler et al. · Gene Therapy · 2001 · 61 citations
Santanu Rana, Kaberi Datta, Lakshminarayan Reddy Teegala et al. · Journal of Controlled Release · 2015 · 40 citations
Jean-Christophe Allo, Patrick Midoux, Marc Merten et al. · American Journal of Respiratory Cell and Molecular Biology · 2000 · 26 citations
1–5 of 9
85
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 85
34
Inserm
Paris, France
2 h-index
20 publications
531 citations
Université Paris Cité
Paris, France
2 h-index
10 publications
261 citations
Guangdong Medical College
Zhanjiang, China
1 h-index
4 publications
100 citations

Université d'Orléans
Orléans, France
1 h-index
9 publications
234 citations
Guangdong Pharmaceutical University
Guangzhou, China
1 h-index
3 publications
75 citations

Sorbonne Université
Paris, France
1 h-index
13 publications
351 citations
Medical Council of Canada
Ottawa, Canada
1 h-index
3 publications
60 citations
Délégation Paris 6
Paris, France
1 h-index
5 publications
135 citations
1–8 of 34
2 publications · 88 citations
2
h-index
1 publications · 186 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 15 citations
1
h-index
1 publications · 40 citations
1
h-index
1–5